Spyre Therapeutics, Inc. (SYRE)

NASDAQ: SYRE · Real-Time Price · USD

17.68

+1.66 (10.36%)

Oct 8, 2025, 4:00 PM EDT - Market closed

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2018	FY 2017	2015 - 2016
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	2015 - 2016
Biopharmaceutical Products	886.00K	Log In	Log In	Log In	Log In	Upgrade
Biopharmaceutical Products Growth	-61.96%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2018	FY 2017	2015 - 2016
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	2015 - 2016
United States	886.00K	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-61.96%	Log In	Log In	Log In	Log In	Upgrade